Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate

被引：0

作者：

Seto, Wai-Kay ^{[2
]}

Asahina, Yasuhiro ^{[3
]}

Peng, Cheng-Yuan ^{[4
]}

Stanciu, Carol ^{[5
]}

Abdurakhmanov, Djamal ^{[6
]}

Flaherty, John F. ^{[1
]}

Kim, Kyungpil ^{[1
]}

Gaggar, Anuj ^{[1
]}

Subramanian, Mani ^{[1
]}

Tabak, Fehmi ^{[7
]}

Nguyen, Tuan T. ^{[8
]}

Chan, Henry Lik-Yuen ^{[9
]}

机构：

[1] Gilead Sci, Foster City, CA USA

[2] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China

[3] Tokyo Med & Dent Univ, Gastroenterol & Hepatol, Tokyo, Japan

[4] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan

[5] Univ Med & Pharm Gr T Popa, Inst Gastroenterol & Hepatol, Iasi, Romania

[6] Univ Clin Hosp 1, Moscow, Russia

[7] Istanbul Univ, Cerrahpassa Tip Fak Hastanesi, Infect Dis, Istanbul, Turkey

[8] Res & Educ Inc, San Diego, CA USA

[9] Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：35A / 35A

页数：1